Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxypeptidase X, M14 family member 1 (CPXM1) is a protein in humans encoded by the CPXM1 gene[7][4][2]. It belongs to the M14 family of zinc-dependent carboxypeptidases and structurally contains a discoidin domain and a carboxypeptidase domain[4]. However, unlike typical carboxypeptidase enzymes, CPXM1 lacks key residues necessary for carboxypeptidase activity and has no detectable enzymatic function[4][2][7]. Evidence suggests CPXM1 is involved in cell-cell interactions and is thought to be an extracellular or cell membrane protein[2][4]. Mutations or altered expression of CPXM1 have been associated with human diseases such as mirror movements 1 and gastric diffuse adenocarcinoma[4]. Currently, no drugs are known to interact with CPXM1, and there are no validated clinical biomarkers or specific safety concerns connected to its modulation. The function of CPXM1 remains incompletely understood, but its structural family places it among metallocarboxypeptidase-like proteins without classical enzymatic activity[7][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxypeptidase X, M14 family member 1 (CPXM1).